Hao Guangshan, Eser Pinar, Mo Jun
Department of Neurosurgery, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu 322000, China.
Department of Neurosurgery, Liaocheng People's Hospital, Liaocheng 252000, China.
Antioxidants (Basel). 2022 Dec 8;11(12):2423. doi: 10.3390/antiox11122423.
Intracranial hypertension is a common phenomenon in patients with aneurysmal subarachnoid hemorrhage (aSAH). Elevated intracranial pressure (ICP) plays an important role in early brain injuries and is associated with unfavorable outcomes. Despite advances in the management of aSAH, there is no consensus about the mechanisms involved in ICP increases after aSAH. Recently, a growing body of evidence suggests that oxidative stress (OS) may play a crucial role in physio-pathological changes following aSAH, which may also contribute to increased ICP. Herein, we discuss a potential relation between increased ICP and OS, and resultantly propose antioxidant mechanisms as a potential therapeutic strategy for the treatment of ICP elevation following aSAH.
颅内高压是动脉瘤性蛛网膜下腔出血(aSAH)患者的常见现象。颅内压(ICP)升高在早期脑损伤中起重要作用,并与不良预后相关。尽管在aSAH的治疗方面取得了进展,但对于aSAH后ICP升高所涉及的机制尚无共识。最近,越来越多的证据表明,氧化应激(OS)可能在aSAH后的生理病理变化中起关键作用,这也可能导致ICP升高。在此,我们讨论ICP升高与OS之间的潜在关系,进而提出抗氧化机制作为治疗aSAH后ICP升高的潜在治疗策略。